SEC Form 4 · accession 0001628280-26-045762
Context Therapeutics Inc. · CNTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip W. Kantoff
Director
Period of report
Jun 24, 2026
Accepted (ET)
Jun 26, 2026 · 4:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001842952
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.576 | Jun 24, 2026 | A | 45,000 | A | — | Jun 23, 2036 | Common Stock | 45,000 | 45,000 | D |
Explanation of responses
- F1The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.